MarketPeel
Insider Trading Intelligence
Pricing
…
PS

Patrick F. Smith

CERT
PRESIDENT, DRUG DEV SOLUTIONS · CERTARA, INC. · CIK 0001890360
FILING MIX · LIFETIME29%/71%
BUYS
10
SELLS
24
TOTAL VALUE
$1.58M
COMPANIES
1
ACTIVE SINCE
Nov 2021
HOLDINGS NOW
50,091
AVG SELL PX
$18.43
TRADE KIND
SHOWING 34 / 34
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
13 backtested trades · 8 horizons · 1 pending
Forward-return performance of every backtestable P/S trade by Patrick F. Smith, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d13+38.46%+2.33%-0.21%+2.54%+6.58%—
14d13+23.08%-0.21%-1.73%+1.52%+3.66%—
30d13+30.77%+2.17%-1.35%+3.52%+6.56%—
60d13+38.46%-2.07%+0.03%-2.10%-1.64%—
90d13+84.62%-10.92%+2.62%-13.54%-24.98%—
180d13+84.62%-17.58%+4.92%-22.50%-41.81%—
1y13+84.62%-21.56%+11.47%-33.03%-46.38%—
2y13(1 pending)+100.00%-49.99%+33.33%-83.32%-96.09%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CERT · 50,091 shares · as of Oct 7, 2024
025,84451,68777,531103,374202220232024SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
FLOW · 10 buys / 24 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CERT
CERTARA, INC.
SALE10b5-1
10b5-1 plan
5,409$11.03$59.7K50,091Oct 7, 2024Oct 8, 2024 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, DRUG DEV SOLUTIONS
1,742$10.99$19.1K55,500Oct 4, 2024Oct 7, 2024 ↗View →
CERT
CERTARA, INC.
PURCHASE
PRESIDENT, DRUG DEV SOLUTIONS
7,151——14,303Oct 4, 2024Oct 7, 2024 ↗View →
CERT
CERTARA, INC.
PURCHASE
PRESIDENT, DRUG DEV SOLUTIONS
7,151——57,242Oct 4, 2024Oct 7, 2024 ↗View →
CERT
CERTARA, INC.
SALE10b5-1
10b5-1 plan
422$17.77$7.5K50,091Apr 2, 2024Apr 4, 2024 ↗View →
CERT
CERTARA, INC.
SALE10b5-1
10b5-1 plan
649$17.72$11.5K58,605Apr 2, 2024Apr 4, 2024 ↗View →
CERT
CERTARA, INC.
SALE10b5-1
10b5-1 plan
4,740$16.77$79.5K50,513Apr 2, 2024Apr 4, 2024 ↗View →
CERT
CERTARA, INC.
SALE10b5-1
10b5-1 plan
5,264$16.76$88.2K59,254Apr 2, 2024Apr 4, 2024 ↗View →
CERT
CERTARA, INC.
SALE10b5-1
10b5-1 plan
328$17.67$5.8K55,253Apr 2, 2024Apr 4, 2024 ↗View →
CERT
CERTARA, INC.
SALE10b5-1
10b5-1 plan
3,024$16.75$50.7K55,581Apr 2, 2024Apr 4, 2024 ↗View →
CERT
CERTARA, INC.
PURCHASE
PRESIDENT, DRUG DEV SOLUTIONS
8,646——62,089Apr 1, 2024Apr 3, 2024 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, DRUG DEV SOLUTIONS
7,852——15,704Apr 1, 2024Apr 3, 2024 ↗View →
CERT
CERTARA, INC.
PURCHASEGRANT
Stock grant
30,381——30,381Apr 1, 2024Apr 3, 2024 ↗View →
CERT
CERTARA, INC.
PURCHASE
PRESIDENT, DRUG DEV SOLUTIONS
7,852——67,208Apr 1, 2024Apr 3, 2024 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, DRUG DEV SOLUTIONS
8,646——8,647Apr 1, 2024Apr 3, 2024 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, DRUG DEV SOLUTIONS
2,690$17.88$48.1K64,518Apr 1, 2024Apr 3, 2024 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, DRUG DEV SOLUTIONS
1,532$17.88$27.4K53,443Apr 1, 2024Apr 3, 2024 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, DRUG DEV SOLUTIONS
2,733$17.88$48.9K59,356Apr 1, 2024Apr 3, 2024 ↗View →
CERT
CERTARA, INC.
SALE10b5-1
10b5-1 plan
5,000$18.00$90.0K54,975Feb 20, 2024Feb 21, 2024 ↗View →
CERT
CERTARA, INC.
PURCHASEGRANT
Stock grant
21,454——21,454Oct 5, 2023Oct 6, 2023 ↗View →
CERT
CERTARA, INC.
SALE10b5-1
10b5-1 plan
19,104$21.55$411.7K59,975Jun 5, 2023Jun 6, 2023 ↗View →
CERT
CERTARA, INC.
PURCHASE
PRESIDENT, INTEGRATED DRUG DEV
23,556——23,556Apr 1, 2023Apr 3, 2023 ↗View →
CERT
CERTARA, INC.
PURCHASE
PRESIDENT, INTEGRATED DRUG DEV
8,646——81,973Mar 31, 2023Apr 3, 2023 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, INTEGRATED DRUG DEV
8,646——17,293Mar 31, 2023Apr 3, 2023 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, INTEGRATED DRUG DEV
2,894$23.80$68.9K79,079Mar 31, 2023Apr 3, 2023 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, INTEGRATED DRUG DEV
1,532$23.80$36.5K73,327Mar 31, 2023Apr 3, 2023 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, INTEGRATED DRUG DEV
2,387$13.48$32.2K74,859Nov 9, 2022Nov 14, 2022 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, INTEGRATED DRUG DEV
1,244$12.23$15.2K77,246Nov 1, 2022Nov 2, 2022 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, INTEGRATED DRUG DEV
10,000$17.71$177.1K78,490Aug 16, 2022Aug 18, 2022 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, INTEGRATED DRUG DEV
10,000$19.16$191.6K88,490Jun 8, 2022Jun 9, 2022 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, INTEGRATED DRUG DEV
3,352$22.29$74.7K98,490Apr 4, 2022Apr 5, 2022 ↗View →
CERT
CERTARA, INC.
SALE
PRESIDENT, INTEGRATED DRUG DEV
1,532$21.48$32.9K101,842Apr 1, 2022Apr 5, 2022 ↗View →
CERT
CERTARA, INC.
PURCHASEGRANT
Stock grant
25,939——25,939Apr 1, 2022Apr 5, 2022 ↗View →
CERT
CERTARA, INC.
PURCHASEGRANT
Stock grant
3,631——103,374Nov 1, 2021Nov 1, 2021 ↗View →
Other insiders · CERT
Loading peer insiders…
About this filer
CIK 0001890360
ROLE
PRESIDENT, DRUG DEV SOLUTIONS
PRIMARY
CERT
COMPANIES
1
ACTIVE SINCE
Nov 2021
MARKETPEEL · /INSIDER/0001890360DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback